Using Hsp70 combined with tumor lysate to promote the efficiency of tumor vaccine
碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 93 === Lung cancer cell derived Heat shock proteins bind with tumor antigens elicted MHC class I restricted antigen-specific CD8+ cytotoxic T-lymphocyte (CTL) response and MHC class II restricted antigen-specific CD4+ response. These responses reject tumor cell growth...
Main Authors: | Zhi- Shen Lai, 賴峙伸 |
---|---|
Other Authors: | Shye-Jye Tang |
Format: | Others |
Language: | zh-TW |
Published: |
2005
|
Online Access: | http://ndltd.ncl.edu.tw/handle/00133162588048767796 |
Similar Items
-
Chicken HSP70 DNA xenogeneic vaccine vaccine inhibits tumor growth in a canine cancer
by: WenYing Yu, et al.
Published: (2010) -
Imaging of Hsp70-positive tumors with cmHsp70.1 antibody-conjugated gold nanoparticles
by: Gehrmann MK, et al.
Published: (2015-09-01) -
HSP70s: From Tumor Transformation to Cancer Therapy
by: Chih-Wen Shu, et al.
Published: (2008-01-01) -
The Modulatory Effect of Hsp70.1 on DNA VaccinationThe Modulatory Effect of Hsp70.1 on DNA Vaccination
by: Weihsu Chen, et al.
Published: (1999) -
Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90
by: Guohua Zhang, et al.
Published: (2017-09-01)